Radnor Capital Management, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,171 filers reported holding NOVARTIS A G in Q4 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.

Quarter-by-quarter ownership
Radnor Capital Management, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$649
-3.7%
6,375
-4.5%
0.13%
-55.2%
Q2 2023$674
+8.2%
6,675
-2.2%
0.29%
+89.5%
Q4 2022$623
-99.9%
6,825
-7.1%
0.15%
-6.2%
Q3 2022$558,000
-6.4%
7,345
+4.3%
0.16%
-0.6%
Q2 2022$596,000
-3.6%
7,0450.0%0.16%
+5.2%
Q1 2022$618,000
-10.6%
7,045
-10.8%
0.16%
-9.4%
Q4 2021$691,000
-11.3%
7,895
-17.1%
0.17%
-63.1%
Q3 2021$779,000
-10.4%
9,5250.0%0.46%
+58.0%
Q2 2021$869,000
+6.8%
9,5250.0%0.29%
+11.8%
Q1 2021$814,000
-15.3%
9,525
-6.4%
0.26%
-3.3%
Q4 2020$961,000
+9.2%
10,175
+0.5%
0.27%
-8.1%
Q3 2020$880,000
-3.0%
10,125
-1.9%
0.30%
-10.1%
Q2 2020$907,000
+6.6%
10,3250.0%0.33%
-6.0%
Q1 2020$851,000
-13.0%
10,3250.0%0.35%
+15.2%
Q4 2019$978,000
+9.0%
10,3250.0%0.30%
+3.1%
Q3 2019$897,000
-4.9%
10,3250.0%0.29%
-5.2%
Q2 2019$943,000
-5.0%
10,3250.0%0.31%
-4.6%
Q1 2019$993,000
+12.1%
10,3250.0%0.32%
+1.6%
Q4 2018$886,000
-0.4%
10,3250.0%0.32%
+13.1%
Q3 2018$890,000
+14.7%
10,325
+0.5%
0.28%
-1.7%
Q2 2018$776,000
-6.6%
10,2750.0%0.29%
+1.8%
Q1 2018$831,000
-9.8%
10,275
-6.4%
0.28%
-4.1%
Q4 2017$921,000
+2.9%
10,975
+2.3%
0.30%
-2.6%
Q3 2017$895,0000.0%10,7250.0%0.30%0.0%
Q2 2017$895,000
+12.3%
10,7250.0%0.30%
+12.6%
Q1 2017$797,000
+3.2%
10,725
+1.2%
0.27%
+1.9%
Q4 2016$772,00010,6000.26%
Other shareholders
NOVARTIS A G shareholders Q4 2022
NameSharesValueWeighting ↓
EXENCIAL WEALTH ADVISORS, LLC 188,514$13,713,0005.95%
PRENTISS SMITH & CO INC 136,441$10,133,0005.74%
MANAGED ASSET PORTFOLIOS, LLC 204,985$15,225,0005.46%
Osher Van de Voorde Investment Management 108,725$8,075,0004.40%
BROWN BROTHERS HARRIMAN & CO 10,796,684$801,870,0004.35%
SECTORAL ASSET MANAGEMENT INC 472,296$35,077,0004.10%
PROFESSIONAL ADVISORY SERVICES INC 235,347$17,479,0003.87%
Elefante Mark B 5,619$417,0003.78%
SPHERA FUNDS MANAGEMENT LTD. 255,000$18,959,0003.71%
CGOV Asset Management 997,161$98,662,0003.61%
View complete list of NOVARTIS A G shareholders